SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 39 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $25,000 | -10.7% | 18,750 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $28,000 | +64.7% | 18,750 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $17,000 | -43.3% | 18,750 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $30,000 | -54.5% | 18,750 | 0.0% | 0.01% | -60.0% |
| Q3 2019 | $66,000 | -4.3% | 18,750 | 0.0% | 0.02% | -6.2% |
| Q2 2019 | $69,000 | -65.0% | 18,750 | 0.0% | 0.02% | -65.2% |
| Q1 2019 | $197,000 | +1.0% | 18,750 | 0.0% | 0.05% | -11.5% |
| Q4 2018 | $195,000 | -13.7% | 18,750 | 0.0% | 0.05% | -7.1% |
| Q3 2018 | $226,000 | +1.8% | 18,750 | 0.0% | 0.06% | +7.7% |
| Q2 2018 | $222,000 | -22.9% | 18,750 | 0.0% | 0.05% | -28.8% |
| Q1 2018 | $288,000 | +14.3% | 18,750 | 0.0% | 0.07% | 0.0% |
| Q4 2017 | $252,000 | -20.3% | 18,750 | 0.0% | 0.07% | -28.4% |
| Q3 2017 | $316,000 | +24.4% | 18,750 | 0.0% | 0.10% | +9.7% |
| Q2 2017 | $254,000 | +52.1% | 18,750 | 0.0% | 0.09% | +38.8% |
| Q1 2017 | $167,000 | – | 18,750 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,301,701 | $4,803,000 | 0.52% |
| SECTORAL ASSET MANAGEMENT INC | 276,656 | $1,021,000 | 0.12% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 277,263 | $1,023,000 | 0.11% |
| CAXTON CORP | 23,821 | $88,000 | 0.10% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $1,522,000 | 0.08% |
| Private Capital Advisors, Inc. | 52,335 | $193,000 | 0.06% |
| Pegasus Asset Management, Inc. | 18,750 | $69,000 | 0.05% |
| Hikari Power Ltd | 61,336 | $226,000 | 0.02% |
| Lee Financial Co | 18,750 | $69,000 | 0.02% |
| Baker Brothers Advisors | 613,144 | $2,263,000 | 0.02% |